Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation
Open Access
- 28 October 2021
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 22 (1) , 9-18
Abstract
Acute Graft versus Host Disease (aGvHD) grades 2–4 occurs in 15–60% of pediatric patients undergoing allogeneic haematopoietic stem-cell transplantation (allo-HSCT). The collateral damage to normal tissue by conditioning regimens administered prior to allo-HSCT serve as an initial trigger for aGvHD. DNA-repair mechanisms may play an important role in mitigating this initial damage, and so the variants in corresponding DNA-repair protein-coding genes via affecting their quantity and/or function. We explored 51 variants within 17 DNA-repair genes for their association with aGvHD grades 2–4 in 60 pediatric patients. The cumulative incidence of aGvHD 2–4 was 12% (n = 7) in the exploratory cohort. MGMT rs10764881 (G>A) and EXO rs9350 (c.2270C>T) variants were associated with aGvHD 2–4 [Odds ratios = 14.8 (0 events out of 40 in rs10764881 GG group) and 11.5 (95% CI: 2.3–191.8), respectively, multiple testing corrected p ≤ 0.001]. Upon evaluation in an extended cohort (n = 182) with an incidence of aGvHD 2–4 of 22% (n = 40), only MGMT rs10764881 (G>A) remained significant (adjusted HR = 2.05 [95% CI: 1.06–3.94]; p = 0.03) in the presence of other clinical risk factors. Higher MGMT expression was seen in GG carriers for rs10764881 and was associated with higher IC50 of Busulfan in lymphoblastoid cells. MGMT rs10764881 carrier status could predict aGvHD occurrence in pediatric patients undergoing allo-HSCT.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030-153389)
- Oak Foundation
- CANSESARCH Foundation, Oak Foundation
- CANSEARCH Foundation
- CANSEARCH Foundation, Oak Foundation
- CANSEARCH Foundation
- The Leukaemia Research and Support Fund
This publication has 34 references indexed in Scilit:
- DNA Damage and Repair in Human Cancer: Molecular Mechanisms and Contribution to Therapy-Related LeukemiasInternational Journal of Environmental Research and Public Health, 2012
- Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donorsBlood, 2010
- DNA repair pathways and their implication in cancer treatmentCancer and Metastasis Reviews, 2010
- Polymorphisms in the base excision repair pathway and graft-versus-host diseaseLeukemia, 2010
- DNA Damage Induced by Alkylating Agents and Repair PathwaysJournal of Nucleic Acids, 2010
- Genomic predictors of interindividual differences in response to DNA damaging agentsGenes & Development, 2008
- Guidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic ConsiderationsClinical Pharmacokinetics, 2006
- Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantationBlood, 2004
- Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDSBlood, 2004
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988